ABC.N
Latest Trade
106.80USDChange
1.16(+1.10%)Volume
2,204,182Today's Range
-
107.8452 Week Range
-
112.45As of on the New York Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 105.64 |
|---|---|
Open | 105.60 |
Volume | 2,204,182 |
3M AVG Volume | 23.32 |
Today's High | 107.84 |
Today's Low | 104.53 |
52 Week High | 112.45 |
52 Week Low | 72.20 |
Shares Out (MIL) | 204.69 |
Market Cap (MIL) | 21,861.21 |
Forward P/E | 12.71 |
Dividend (Yield %) | 1.65 |
Amerisourcebergen Sees FY 2021 Adjusted Earnings Per Share $8.25 To $8.50
AmerisourceBergen And Walgreens Boots Alliance Announce Strategic Transaction
Lilly's Neutralizing Antibody Receives FDA Emergency Use Nod For Treatment Of Recently Diagnosed COVID-19
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
Industry
Biotechnology & Drugs
Contact Info
1300 Morris Dr
CHESTERBROOK, PA
19087-5594
United States
+1.610.7277000
Executive Leadership
Steven H. Collis
Chairman of the Board, President, Chief Executive Officer
James F. Cleary
Chief Financial Officer, Executive Vice President
Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Gina K. Clark
Executive Vice President, Chief Communications & Administration Officer
John G. Chou
Executive Vice President, Chief Legal Officer and Secretary
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 0.12 |
Price To Book (MRQ) | -- |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | -- |
LT Debt To Equity (MRQ) | -- |
Return on Investment (TTM) | -34.48 |
Return on Equity (TTM) | -8.15 |
Walgreens Boots Alliance Inc said on Thursday it expects benefits from COVID-19 vaccinations to cushion the impact of pandemic-induced restrictions, and stuck to its full-year earnings growth forecast, sending its shares up 7%.
U.S. drug wholesaler AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business for $6.5 billion to expand in Europe as well as to compete better in the U.S. healthcare sector.
Drug distributor AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business, Alliance Healthcare, for $6.5 billion.
FedEx Corp's Canadian subsidiary and Innomar Strategies, a Canada-based unit of U.S. drug distributor AmerisourceBergen Corp said on Thursday they have started to distribute Moderna Inc's COVID-19 vaccine across Canada.
A judge in Washington state has found drug distributor AmerisourceBergen in contempt for failing to turn over records from its board or make key witnesses available to testify in a lawsuit by the state alleging it fueled the opioid crisis.
McKesson Corp and two other drug distributors could be expected pay up to $21 billion for the potential settlement of lawsuits alleging the companies fueled the U.S. opioid epidemic, the company said on Tuesday.
Drug wholesaler AmerisourceBergen Corp and some of its executives and directors must face a shareholder lawsuit over its sale of unsterile chemotherapy drugs and payments of kickbacks to doctors, which have already resulted in $885 million in criminal and civil penalties...
* U.S. STATES SEEK $26.4 BILLION FROM DRUG COMPANIES IN OPIOID LITIGATION- WSJ
* AMERISOURCEBERGEN SELECTED BY DECIPHERA PHARMACEUTICALS TO SUPPORT QINLOCK™ Source text for Eikon: Further company coverage:
* AMERISOURCEBERGEN PRICES $500 MILLION 2.800% SENIOR NOTES DUE 2030 Source text for Eikon: Further company coverage:
* AMERISOURCEBERGEN REPORTS FISCAL 2020 SECOND QUARTER RESULTS
AmerisourceBergen Corp <ABC.N>, one of the largest U.S. drug distributors, has approached Walgreens Boots Alliance Inc <WBA.O> to explore a deal for its pharmaceutical wholesaling division, people familiar with the matter said on Monday.
* PROXY ADVISORY FIRM PIRC RECOMMENDS AMERISOURCEBERGEN CORP SHAREHOLDERS TO VOTE AGAINST RESOLUTION TO ELECT CEO STEVEN H COLLIS AS DIRECTOR
Vice-Chancellor Travis Laster of Delaware Chancery Court signaled Wednesday that he really did intend to reset the course of books-and-records litigation when he ruled last month that the wholesale pharmaceutical distributor AmerisourceBergen give shareholders formal board...
There is a reasonable possibility, according to Vice-Chancellor Travis Laster, that shareholders of the wholesale pharmaceutical distributor AmerisourceBergen Corporation will turn out to have an actionable claim that the company’s directors breached their fiduciary duties...
AmerisourceBergen has lost a bid to keep secret material related to the drug distributor's internal program for monitoring for suspicious orders in a lawsuit by New York's attorney general accusing the company of fueling the opioid epidemic.
AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.
AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.
Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.
Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.